Tenders Are Invited For Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V (Open House Modell)

Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V (Open House Modell). Under The Specification Of Uniform Contractual Conditions And Uniform Access Procedures, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Is Offered The Conclusion Or Accession To A Discount Contract In Accordance With Section 130 A (8) Sgb V For The Active Ingredients Mentioned. Interested Pharmaceutical Companies Can Request The Participation Documents And The Contract At The Contact Address (Am- Contract [email protected]). The Prerequisite For The Conclusion Of A Contract Is That The Interested Pharmaceutical Company Fully Filled Out The Requested Participation Documents, Stamped Stamped And Signed In The Original. A Contract Is Concluded With Every Pharmaceutical Company That Meets The Prerequisites For Participation. There Is No Exclusivity. The Present Publication Is Not The Allocation Of A Public Mandate Within The Meaning Of Directive 2014/24/Eu Or The Public Procurement Law. In Order To Ensure A Largest Degree Of Transparency For The Intended Contract Conclusions, The Publication Is Published In The Supplement To The Official Journal Of The European Union. In The Absence Of A Corresponding Publication Form, The Order Announcement Is Used. The Resulting Conceptual Requirements, Such As The Procedural Name Open Procedure, Are Only Due To The Use Of This Announcement Form And The Publication Platform. Another Meaning, In Particular A Submission Under Public Procurement Law, Unless They Are Mandatory For Legal Reasons, Is Not Associated With This.